CGON vs COF · $4.74B cap vs P/E 62, rev $53.43B
CG Oncology, Inc. Common stock (CGON) versus Capital One Financial Corporation (COF) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
CGON does not have a complete income-statement cache yet.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
CGON currently screens at market cap $4.74B. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Not investment advice. Open the CGON and COF stock pages for the full models.
Not investment advice.